Mechanistic Evaluation of Guanfacine on Drinking Behavior



Status:Recruiting
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:21 - 65
Updated:2/22/2019
Start Date:March 1, 2019
End Date:September 29, 2020
Contact:Meaghan Lavery
Email:meaghan.lavery@yale.edu
Phone:203-737-2783

Use our guide to learn which trials are right for you!

Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders

For this protocol, the investigators plan to collect pilot data to examine sex differences in
guanfacine's effect on 1) counteracting stress and stimulation based drinking behavior in the
laboratory and 2) improving clinical outcomes during a subsequent treatment phase.


Inclusion Criteria:

1. Age 21-65

2. Able to read and write English

3. Meets Diagnostic and Statistical Manual (DSM)-5 criteria for current (past 6 months)
alcohol use disorder (AUD)

4. Meets criteria for NIAAA defined risky drinking

5. Able to take oral medications and willing to adhere to medication regimen

Exclusion Criteria:

1. Participants with any significant current medical conditions

2. Women who are pregnant or nursing, or fail to use one of the following methods of
birth control unless she or her partner is surgically sterile or she is postmenopausal
(hormone contraceptives [oral, implant, injection, patch, or ring], contraceptive
sponge, double barrier [diaphragm or condom plus spermicide], or intrauterine device
[IUD])

3. Suicidal, homicidal or evidence of current (past 6 months) mental illness

4. Specific exclusions for administration of guanfacine not already specified

5. Subjects likely to exhibit clinically significant alcohol withdrawal during the study.
We found this trial at
1
site
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Principal Investigator: Sherry McKee, PhD
Phone: 203-737-2783
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
?
mi
from
New Haven, CT
Click here to add this to my saved trials